Jiumao Lin

Dr. Jiumao Lin


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2015 in Molecules
Verified
Journal Article
Open access
PDF file
DCDaxin Chen
Daxin Chen
SLShan Lin
Shan Lin
WXWen Xu
Wen Xu
MHMing-Qing Huang
Ming-Qing Huang
CJChu Jianfeng
Chu Jianfeng
JPJun Peng
Jun Peng
Shexiang Tongxin dropping pill (STP) is a traditional Chinese medicine formula that consists of total saponins of ginseng, synthetic Calculus bovis, bear gall, Venenum bufonis, borneol and Salvia miltiorrhiza. STP has been widely used in China and Southeast Asia for the treatment of cardiovascular diseases. In this study, a qualitative analytical method using high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry was developed for identification of the major constituents in STP. Based on the retention time and MS spectra, 41 components were identified by comparison with reference compounds and literature data. Moreover, using ultra-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry in multiple-reaction monitoring mode, we quantified 13 of the identified constituents (ginsenoside Rg1, ginsenoside Rk3, cinobufagin, arenobufagin, bufalin, resibufogenin, tanshinone IIA, taurine, tauroursodeoxycholic acid, taurocholic acid, cholic acid, deoxycholic acid, and chenodeoxycholic acid). These results suggest that this new approach is applicable for the routine analysis and quality control of STP products and provides fundamental data for further in vivo pharmacokinetical studies.

12 October 2015 in International Journal of Oncology
Verified
Journal Article
Closed access
LLLi Li
Li Li
LWLihui Wei
Lihui Wei
ASAling Shen
Aling Shen
JCJianfeng Chu
Jianfeng Chu
JLJiumao Lin
Jiumao Lin
JPJun Peng
Jun Peng
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

13 April 2016 in Oncology Letters
Verified
Journal Article
Open access
PDF file
GSGuodong Sun
Guodong Sun
LWLihui Wei
Lihui Wei
JFJianyu Feng
Jianyu Feng
JLJiumao Lin
Jiumao Lin
JPJun Peng
Jun Peng
Cancer stem cells (CSCs) are proposed to be closely correlated with the development and progression of tumors, as well as with chemo- and radioresistance. Targeting CSCs may therefore be a promising potential strategy for the treatment of cancer. Currently, natural products have received great interest due to their therapeutic efficacy and reduced adverse effects compared with modern chemotherapeutics. As a significant component of a number of traditional Chinese medicine formulas, the medicinal herb Hedyotis diffusa Willd. (HDW) has long been utilized in China to clinically treat a variety of malignancies, including colorectal cancer (CRC). Previously, the authors of the present study reported that HDW suppressed CRC growth through multiple mechanisms, including promoting apoptosis, and inhibiting cell proliferation and tumor angiogenesis. To additionally investigate its mode of action, the present study isolated a stem-like side population (SP) from colorectal cancer HT-29 cells to investigate the effect of ethanol extract of HDW on CSCs. It was observed that HDW was able to markedly downregulate the expression of CSC marker leucine-rich repeat-containing G-protein coupled receptor 5 and also significantly decrease the proportion of SP in HT-29 cells, in a dose-dependent manner. Furthermore, HDW treatment significantly and dose-dependently inhibited the viability and sphere formation, and induced cell morphological changes of isolated HT-29 SP cells. In addition, HDW greatly suppressed the messenger RNA expression of several critical genes that mediate CSC features, including ATP-binding cassette, sub-family B, member 1, β-catenin, c-Myc, proliferating cell nuclear antigen and survivin. In conclusion, the present study indicates that HDW may exert inhibitory effects on cancer stem cells.

1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ASAling Shen
Aling Shen
HCHongwei Chen
Hongwei Chen
YCYouqin Chen
Youqin Chen
JLJiumao Lin
Jiumao Lin
WLWei Lin
Wei Lin
JPJun Peng
Jun Peng
The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5‐FU resistant human colorectal carcinoma cell line (HCT‐8/5‐FU) to evaluate the effects of PZH on multidrug resistance (MDR) and epithelial‐mesenchymal transition (EMT) as well as the activation of TGF‐β pathway. We found that PZH dose‐dependently inhibited the viability of HCT‐8/5‐FU cells which were insensitive to treatment of 5‐FU and ADM, demonstrating the ability of PZH to overcome chemoresistance. Furthermore, PZH increased the intercellular accumulation of Rhodamine‐123 and downregulated the expression of ABCG2 in HCT‐8/5‐FU cells. In addition, drug resistance induced the process of EMT in HCT‐8 cells as evidenced by EMT‐related morphological changes and alteration in the expression of EMT‐regulatory factors, which however was neutralized by PZH treatment. Moreover, PZH inhibited MDR/EMT‐enhanced migration and invasion capabilities of HCT‐8 cells in a dose‐dependent manner and suppressed MDR‐induced activation of TGF‐β signaling in HCT‐8/5‐FU cells. Taken together, our study suggests that PZH can effectively overcome MDR and inhibit EMT in human colorectal carcinoma cells via suppression of the TGF‐β pathway.

1 May 2017 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
ZLZijun Lai
Zijun Lai
ZYZhaokun Yan
Zhaokun Yan
WCWujin Chen
Wujin Chen
JPJun Peng
Jun Peng
JFJianyu Feng
Jianyu Feng
JLJiumao Lin
Jiumao Lin
Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract, and threatens the survival and health of patients with CRC. Chemotherapy remains one of the main therapeutic approaches for patients with CRC; however, drug resistance limits the long‑term use. CRC cells with multi‑drug resistance (MDR) exhibit increased survival times and metastatic potential, which may lead to the recurrence and metastasis of CRC. In addition, MDR is one of the major causes of chemotherapy failure in clinical treatment. Hedyotis diffusa Willd (HDW) has been used in the treatment of inflammation‑associated diseases and malignant tumors, including CRC. The authors previously demonstrated that HDW could reverse MDR in CRC cells; however, its underlying mechanism, particularly in MDR‑associated metastasis, remains to be elucidated. In the present study, the drug‑resistant CRC cell line HCT‑8/5‑fluorouracil (5‑FU) was used to investigate the effect of HDW on the growth and metastasis of cancer cells. Cell viability was assessed using the MTT assay. Cell adhesion potential was evaluated using adhesion experiments. Cell migration was assessed using wound healing and Transwell assays. The mRNA and protein expression levels of crucial factors in the transforming growth factor‑β (TGF‑β) signaling pathway, including TGF‑β, Mothers against decapentaplegic homolog 4 (SMAD4), neural (N)‑cadherin, and epithelial (E)‑cadherin, were analyzed using the reverse transcription‑semi‑quantitative polymerase chain reaction and western blotting, respectively. The results demonstrated that the HCT‑8/5‑FU cell line was more resistant to 5‑FU and thus can be used as the resistant cell model. HDW was able to inhibit the viability, and adhesive, migratory and invasion potential of the HCT‑8/5‑FU cells. In addition, HDW was able to downregulate the expression of TGF‑β, SMAD4 and N‑cadherin, and upregulate E‑cadherin, at the gene and protein level. In conclusion, the results demonstrated that HDW may suppress the metastasis of 5‑FU‑resistant CRC cells via regulation of the TGF‑β signaling pathway, which was also considered to be one of the underlying mechanisms of its anti‑CRC effect.

2 October 2017 in Experimental and Therapeutic Medicine
Verified
Journal Article
Closed access
PDF file
YJYiyi Jin
Yiyi Jin
WCWujin Chen
Wujin Chen
HYHong Yang
Hong Yang
ZYZhaokun Yan
Zhaokun Yan
ZLZijun Lai
Zijun Lai
JLJiumao Lin
Jiumao Lin
Metastasis is one of the most aberrant behaviors of cancer cells. Patients with cancers, including colorectal cancer (CRC), have a higher risk of tumor recurrence and cancer‑related mortality once metastasis is diagnosed. Existing treatment strategies fail to cure cancer mostly due to the onset of metastasis. Therefore, metastasis remains a challenge in cancer treatment. Some complementary and alternative medical therapies using traditional Chinese medicine have been demonstrated to be clinically effective in cancer treatment. Scutellaria barbata D. Don (SB) is a promising medicinal herb. It was previously reported that the ethanol extract of SB (EESB) is able to promote apoptosis, and inhibit cell proliferation and angiogenesis in human colon cancer cells. However, the anticancer effect of SB and the underlying mechanism require further investigation, particularly its role against metastasis. To further elucidate the antimetastatic effect of SB, MTT and Transwell assays were used in the present study to evaluate the effect of EESB on the proliferation, migration and invasion of the CRC cell line HCT‑8. In addition, western blot analysis was performed to detect the expression of matrix metalloproteinases (MMPs), cadherins and other metastasis‑associated proteins. EESB significantly reduced HCT‑8 cell viability and attenuated the migration and invasion ability of HCT‑8 cells in a dose‑dependent manner. In addition, EESB decreased the expression of MMP‑1, MMP‑2, MMP‑3/10, MMP‑9 and MMP‑13, and proteins in the phosphoinositide 3‑kinase (PI3K)/AKT and transforming growth factor (TGF)‑β/Smad pathways, but not the epithelial‑mesenchymal transition (EMT)‑related factors E‑cadherin and N‑cadherin. In conclusion, the results suggested that SB inhibits CRC cell metastasis via the suppression of PI3K/AKT and TGF‑β/Smad signaling pathways, which may represent a mechanism by which SB exerts an anticancer effect.